Share
Market Research Report

OPIOID DRUGS MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)

Segmentation
  • By Drug ClassAlkaloids (Morphine, codeine) · Semisynthetic Opioids (Oxycodone, Hydrocodone, Hydromorphone) · Synthetic Opioids (Fentanyl, Alfentanil)
  • By ApplicationAnalgesia · Cough Suppression · Diarrhea Suppression · Others
  • By Route of AdministrationOral · Topical · Parenteral · Others (Intramuscular, etc.)
  • By Distribution ChannelHospital Pharmacies · Retail Pharmacies · Online Pharmacies
  • By GeographyNorth America · Latin America · Europe · Asia Pacific · Middle East & Africa
  • Published In01 Apr 2026
  • Report CodeCMI1017
  • Pages250+
  • FormatsExcel and PDF
  • Base Year2025
  • Estimated Year2026
  • Historical Range2020 - 2024
  • Forecast Period2026-2033
  1. Research Objective and Assumption

    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview

    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Drug Class
      • Market Snippet, By Application
      • Market Snippet, By Route of Administration
      • Market Snippet, By Distribution Channel
      • Market Snippet, By Region
      • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis

    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Recent Product Launches
    • Epidemiology
    • Merger, Acquisition, and Collaborations
    • Regulatory Scenario
    • Key Developments
    • Reimbursement Scenario
    • PEST Analysis
    • PORTER’S Analysis
  4. Global Opioid Drugs Market, By Drug Class, 2021 - 2033, (USD Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022-2033
      • Segment Trends
    • Alkaloids
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
      • Segment Trends
        • Morphine
        • codeine
    • Semisynthetic Opioids
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
      • Segment Trends
        • Oxycodone
        • Hydrocodone
        • Hydromorphone
    • Synthetic Opioids
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
      • Segment Trends
        • Fentanyl
        • Alfentanil
  5. Global Opioid Drugs Market, By Application, 2021 - 2033, (USD Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022-2033
      • Segment Trends
    • Analgesia
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
      • Segment Trends
    • Cough Suppression
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
      • Segment Trends
    • Diarrhea Suppression
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
      • Segment Trends
  6. Global Opioid Drugs Market, By Route of Administration, 2021 - 2033, (USD Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022-2033
      • Segment Trends
    • Oral
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
      • Segment Trends
    • Topical
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
      • Segment Trends
    • Parenteral
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
      • Segment Trends
    • Others (Intramuscular, etc.)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
      • Segment Trends
  7. Global Opioid Drugs Market, By Distribution Channel, 2021 - 2033, (USD Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022-2033
      • Segment Trends
    • Hospital Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Retail Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
    • Online Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  8. Global Opioid Drugs Market, By Region, 2021 - 2033, (USD Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022-2033
      • Segment Trends
    • North America
      • Introduction
      • Market Size and Forecast, Y-o-Y Growth and By Drug Class, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, Y-o-Y Growth and By Application, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, By Country, Y-o-Y Growth and By Country,  2021 - 2033, (USD Bn)
        • U.S.
        • Canada
    • Latin America
      • Introduction
      • Market Size and Forecast, Y-o-Y Growth and By Drug Class, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, Y-o-Y Growth and By Application, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, By Country, Y-o-Y Growth and By Country,  2021 - 2033, (USD Bn)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • Introduction
      • Market Size and Forecast, Y-o-Y Growth and By Drug Class, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, Y-o-Y Growth and By Application, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, By Country, Y-o-Y Growth and By Country,  2021 - 2033, (USD Bn)
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Introduction
      • Market Size and Forecast, Y-o-Y Growth and By Drug Class, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, Y-o-Y Growth and By Application, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, By Country, Y-o-Y Growth and By Country,  2021 - 2033, (USD Bn)
        • China
        • India
        • Japan
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia Pacific
    • Middle East
      • Introduction
      • Market Size and Forecast, Y-o-Y Growth and By Drug Class, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, Y-o-Y Growth and By Application, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, By Country, Y-o-Y Growth and By Country,  2021 - 2033, (USD Bn)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Introduction
      • Market Size and Forecast, Y-o-Y Growth and By Drug Class, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, Y-o-Y Growth and By Application, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, Y-o-Y Growth and By Route of Administration, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, By Country, Y-o-Y Growth and By Country,  2021 - 2033, (USD Bn)
        • North Africa
        • Central Africa
        • South Africa
  9. Competitive Landscape

    • Company Profiles
      • Teva Pharmaceutical Industries Ltd.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Johnson & Johnson
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Endo International plc
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Lupin Limited
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Cadila Healthcare Limited
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Purdue Pharma L.P.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • AbbVie Inc.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Fresenius Kabi
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Mallinckrodt Pharmaceuticals
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Pfizer Inc.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Rhodes Pharmaceuticals L.P.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Sun Pharmaceutical Industries Limited
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Nesher Pharmaceuticals (USA) LLC
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Amneal Pharmaceuticals LLC
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Trevena Inc.
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
      • Aurobindo Pharma Limited
        • Company Overview
        • Product Portfolio
        • Key Highlights
        • Financial Overview
        • Strategies
  10. Section

    • References
    • Research Methodology
    • About us and Sales Contact